We found no evidence that induction of labour increases the caesarean rate or compromises neonatal outcome as compared with expectant management. Concerns over increased risk of failed induction in women with a Bishop score from 3 to 6 seem unwarranted.
Objective To evaluate caesarean section and adverse neonatal outcome rates after induction of labour or expectant management in women with an unripe cervix at or near term.
Design Secondary analysis of data from two randomised clinical trials.
Setting Data were collected in two nationwide Dutch trials.
Population Women with hypertensive disease (HYPITAT trial) or suspected fetal growth restriction (DIGITAT trial) and a Bishop score ≤6.
Methods Comparison of outcomes after induction of labour and expectant management.
Main outcome measures Rates of caesarean section and adverse neonatal outcome, defined as 5-minute Apgar score ≤6 and/or arterial umbilical cord pH <7.05 and/or neonatal intensive care unit admission and/or seizures and/or perinatal death.
Results
Of 1172 included women with an unripe cervix, 572 had induction of labour and 600 had expectant management. We found no significant difference in the overall caesarean rate (difference À1.1%, 95% CI À5.4 to 3.2). Induction of labour did not increase caesarean rates in women with Bishop scores from 3 to 6 (difference À2.7%, 95% CI À7.6 to 2.2) or adverse neonatal outcome rates (difference À1.5%, 95% CI À4.3 to 1.3). However, there was a significant difference in the rates of arterial umbilical cord pH <7.05 favouring induction (difference À3.2%, 95% CI À5.6 to À0.9). The number needed to treat to prevent one case of umbilical arterial pH <7.05 was 32.
Introduction
Induction of labour (IOL) is a common practice in obstetrics,with estimates ranging from 20 to 25% of all pregnancies. 1, 2 IOL is indicated in situations in which the outcomes for mother and child are better if the pregnancy is not further prolonged. 2 The effectiveness of IOL is subject to considerable debate, especially due to concerns over associated high rates of caesarean sections (CS) in women with an unripe cervix. 3 The ripeness of a cervix is often characterised through the Bishop score (BS). 4 However, the use of the BS for the prediction of the delivery mode in women scheduled for IOL at term has been recently questioned. 5 Nonetheless, IOL is identified by multiple studies as a risk factor for CS for both nulliparous and parous women. [6] [7] [8] [9] [10] [11] [12] However, these studies compared CS rates after IOL with those after spontaneous labour. This comparison has been criticised as inappropriate because spontaneous labour is not a management choice of the attending physician. In complicated pregnancies, the two available options are: (1) expectant management (EM) until spontaneous labour starts or clear indications for immediate delivery appear and (2) delivery by IOL or CS. 13 In a randomised trial with EM as the comparison group, IOL has been shown to produce lower CS rates in post-term women. 14 This trial was included in a recent meta-analysis that showed reduced CS risk after IOL in women with intact membranes. 15 Furthermore, two recent randomised trials, HYPITAT (Hypertension and Pre-eclampsia Intervention Trial At Term) and DIGITAT (Disproportionate Intrauterine Growth Intervention Trial At Term), found comparable CS rates after IOL in term pregnancies complicated by hypertensive disease or fetal growth restriction (IUGR). The HYPITAT trial showed that IOL lowers the risk of severe hypertension whereas the DIGITAT study showed it not to be harmful, thus possibly allowing for the prevention of stillbirth. [16] [17] [18] [19] Short-and long-term consequences of near (35-37) and early term (37-38) birth should also be taken into account as IOL inevitably produces lower gestational ages at delivery. [20] [21] [22] The appropriate management of women with an indication for IOL who also present with an unripe cervix remains elusive. In these women, IOL is not regarded as an appealing option because of the possibility of a long cervical ripening process, which conflicts with the pressing need for rapid delivery. The prospect of a higher risk of CS in case IOL fails, may further influence the preference for immediate CS. In this study we evaluated CS and adverse neonatal outcome rates in women whose pregnancies were complicated by hypertensive disease or IUGR and who presented with an unripe cervix in a combined data set from two randomised trials that compared IOL with EM.
Methods
Our analyses were based on the combined data from the multicentre, open-label, controlled randomised trials HYPI-TAT and DIGITAT. 16, 17 The trials were approved by the Institutional Review Board of the University of Leiden (p04.210). Both compared EM with IOL in women with a singleton fetus in cephalic presentation recruited between 36 and 41 weeks for either gestational hypertension or mild pre-eclampsia in the HYPITAT trial or suspected IUGR in the DIGITAT trial. Recruitment periods of HYPITAT and DIGITAT overlapped (October 2005-March 2008 and November 2004-November 2008, respectively) and women were assigned preferentially to DIGITAT if they presented with hypertension and suspected IUGR. Further details on each trial have been described previously. 16, 17 Gestational hypertension was defined as two measurements of diastolic blood pressure ≥95 mmHg at least 6 hours apart. Mild pre-eclampsia was defined as diastolic blood pressure ≥90 mmHg measured twice at least 6 hours apart and proteinuria (two or more positives on a dipstick, >300 mg total protein on a 24-hour urine sample or protein to creatinine ratio >30 mg/mmol). 23 Suspected IUGR was defined as one or more of fetal abdominal circumference, weight below the 10th percentile or flattening of the growth curve in the third trimester. 24 Maternal exclusion criteria were previous CS, pre-existing hypertension, diabetes mellitus or gestational diabetes requiring insulin therapy, HIV seropositivity, HELLP syndrome, renal or heart disease, oliguria (<500 ml/24 hours), pulmonary edema, cyanosis and prelabour rupture of membranes. The use of intravenous antihypertensive drugs was also an exclusion criterion as well as severe gestational hypertension and pre-eclampsia, which were defined as systolic blood pressure ≥170 mmHg, diastolic blood pressure ≥110 mmHg or proteinuria ≥5 g/24 hours. Fetal abnormalities suspected on ultrasound or during fetal heart-rate monitoring, and decreased or absent fetal movements were also exclusion criteria.
After written informed consent was obtained, women were randomly allocated to either IOL or EM. For this study, we selected the women with an unripe cervix at inclusion, defined as a BS ≤6. 4 In the IOL group, labour was induced within 24 hours of randomisation in HYPI-TAT and within 48 hours in DIGITAT. Cervical ripening was promoted with intracervical or intravaginal prostaglandins or a balloon catheter, according to local protocols.
Women in the EM group were monitored until spontaneous onset of labour. Twice weekly blood pressure measurements and screening for proteinuria using a dipstick or protein to creatinine ratio in a urine sample were performed as well as laboratory tests of liver and kidney function and full blood count. Positive screening of proteinuria was followed by the collection of urine for 24 hours to quantify proteinuria levels. Assessment of the fetal conditions consisted of electronic fetal heart-rate monitoring, ultrasound examination, and daily reports on fetal movement by the woman. IOL was performed in this group if during monitoring a woman exhibited systolic blood pressure ≥170 mmHg, diastolic blood pressure ≥110 mmHg, proteinuria ≥5 g/24 hours, eclampsia, HELLP syndrome, suspected fetal distress (defined as a non-reassuring fetal heart rate (suboptimal, abnormal or pre-terminal CTG), absence or a decrease in fetal movements, and/ or a fetal scalp pH during labour below <7.20), prelabour rupture of membranes >48 hours, meconium-stained amniotic fluid, fetus gestational age beyond 41 weeks as well as at the obstetrician's discretion.
The primary outcomes of this study were CS and a composite adverse neonatal outcome. The composite adverse neonatal outcome was defined as the presence of at least one of the following: 5-minute Apgar score ≤6, arterial umbilical cord pH <7.05, neonatal intensive care (NICU) admission, seizures or perinatal death. Each of these was defined individually as a secondary outcome. If the umbilical artery pH was missing, in both trials the neonatal outcome was classified as normal if all other components of the composite outcome were normal. For the present analyses we did the same for cases of missing data on NICU admission and seizures. We performed subgroup analyses of the primary outcomes by each BS level as well as through the use of the median BS level. Mann-Whitney Utests, chi-squared statistics and Wilson's method for differences in proportions were used as appropriate. To check for potential confounders in the analyses we performed logistic regressions.
Results
During the original trial periods, 756 and 650 eligible women were randomised in the HYPITAT and DIGITAT trials, respectively. Of these 1406 women, 1172 (83.3%) had a BS ≤6 and fulfilled all other criteria for these analyses. After random allocation, 572 were assigned to IOL and 600 to EM (see Figure S1 ).
Baseline characteristics are presented in Table 1 . The groups were comparable with respect to their median maternal age, BMI at booking, gestational age, BS and cervical length at randomisation. The proportion of women selected from the two trials in both intervention and control groups was similar, as was the number of women with hypertensive disease. The proportions of nulliparas, white Europeans and smokers were also comparable between the two groups. Table 2 shows labour and delivery data for both groups. In the IOL group, 17 (3%) women had spontaneous labour before induction was started. In the EM group, labour was induced in 288 (48%) women, either according to the monitoring protocol (n = 235, 81.6%) or electively (n = 53, 18.4%). Planned CS was indicated for three women in the induction group: one due to fetal distress, another due to maternal complications and the third was an elective procedure. Of the 15 planned CS that occurred in the EM group, 11 were indicated due to fetal distress, one due to maternal complications and three were elective procedures.
CS was performed in 88 (15.4%) and 99 (16.5%) women in the IOL and EM groups, respectively (difference À1.1%; 95% CI À5.4 to 3.2). Fetal distress was the indication of 40 CS in the IOL group, identical in proportion to the 45 in the EM group (45.4 versus 45.4%). We also found similar rates for instrumental vaginal deliveries (10.1 versus 11.7%) in both groups (difference À1.6%; 95% CI À5.2 to 2.2).
Data on overall time from randomisation to delivery as well as by levels of BS and parity are presented in Table S1 . Of the 572 women in the IOL group, 426 (75%) delivered within 2.5 days. As expected, there was a significant difference in median time from randomisation to delivery (1.7 versus 8.9 days; P < 0.001). This difference was reflected in the median gestational age at delivery (268.1 versus 278.3 days; P < 0.001). As expected, the difference in time from randomisation to delivery decreased with increasing BS at randomisation. In the subgroup of 65 women randomised with a BS of 6, it decreased to 3.5 days (1.4 versus 4.9 days; P < 0.001). The median number of hours from induction start to birth was 3.3 hours lower in the EM group (12.2 versus 8.9 hours; P < 0.001). Induction in the EM group was performed at a median of 8.8 (IQR 4.7-14.1) days from randomisation.
Neonatal outcomes can be found in Table 3 . Median birthweight was lower in the IOL group (2888 versus 2998 g; difference À110 g; P < 0.001). The highest difference in median birthweight was found in the subgroup of women who presented hypertensive disease (3225 versus 3480 g; difference À255; P < 0.001). In the 61 (5%) pregnancies that were complicated by both hypertensive disease and IUGR we found no significant difference in median birthweight between the groups. In these women, the median time from randomisation to delivery was 1.3 days (IQR 0.9-2.7) in the induction group and 6.7 days (IRQ 3.0-14.0) in the EM group.
There was no perinatal mortality. Two newborns exhibited seizures, one in each group. The number of neonates with an adverse neonatal outcome in the induction group was 32 (5.7%), comparable to the 42 (7.2%) in the EM group (difference À1.5%; 95% CI À4.3 to 1.3). The groups did not differ with respect to NICU admission rates: 14 (2.6%) in each group were admitted. Twelve presented 5minute Apgar scores below 7 in the IOL group, one more than in the EM group. A significant difference was found in the number of newborns with umbilical arterial pH below 7.05: eight in the IOL group and 24 in the EM group with this condition (1.7 versus 4.8%; difference À3.2%; 95% CI À5.6 to À0.9). With the limit at 7.01, there was one child in the IOL group and 14 in the EM group (0.2 versus 2.8%, difference À2.6%, 95% CI À4.2 to À1.1). To avoid one case of umbilical artery pH <7.05, 32 (95% CI 18-112) women would need to be induced and this number rises to 39 (95% CI 23-90) for pH <7.01. Table 4 presents the main outcomes by different BS subgroups. We used the median BS at randomisation of three to divide the sample in two subgroups: BS from 0 to 2 and BS from 3 to 6. In the subgroup with BS 0-2 there were 59 (22.7%) CS in the IOL group and 62 (21.2%) in the EM group (difference 1.5%; 95% CI À5.4 to 8.4). The CS rates remained comparable between IOL and EM if the analysis was restricted to the women randomised with BS 3-6, although the numbers were approximately halved to 29 (9.3%) and 37 (12%) (difference À2.7%; 95% CI À7.6 to 2.2). Comparison within the IOL group showed that the higher CS rate found in women with BS 0-2 was significantly different from women with scores from 3 to 6 (22.7% versus 9.3%; difference 13.4%; 95% CI 7.5-19.3). Comparable results were found in the EM group (21.2% versus 12%; difference 9.2%; 95% CI 3.3-15.1). Rates of adverse neonatal outcomes were comparable in all subgroups. Further analyses of the main outcomes by parity and Bishop scores are shown in Table S2 .
Logistic regression was used to adjust for possible confounders and several candidates (age, parity, trial, ethnicity, presence and type of hypertensive disease, dipstick proteinuria level, BMI, cervical length, gestational age and BS at inclusion) were considered but none achieved statistical significance or changed the odds ratio of the intervention variable by more than 10%.
Discussion

Main findings
Through analyses of a combined data set of the HYPITAT and DIGITAT trials we were able to show that IOL when compared with EM is not associated with increased rates of CS or adverse neonatal outcomes in term or near term pregnancies complicated by IUGR, gestational hypertension or pre-eclampsia even in women with an unripe (BS ≤6) or very unripe (BS ≤2) cervix and an indication for 'shortterm' delivery. Although we confirmed the expected relation between a low Bishop score and a longer labour and higher caesarean section rate, this relation occurred irrespective of whether labour was induced straightaway, or expectant management was adopted. Women with BS between 3 and 6 had a CS rate of 9.3% after IOL. These results suggest that concerns over a high risk of failed induction in women with BS between 3 and 6 are unwarranted.
Strengths and limitations
We were able to analyse a large data set of women with term pregnancies, whose management was determined by randomisation to either IOL or expectant management. Bishop score did not play a role in the allocation. Therefore, selection bias in our study is unlikely. Moreover, the sample size allowed detection of clinically relevant differences for the main outcomes. A possible limitation may be that our study was based on women with complicated pregnancies, so the results cannot be immediately generalised to uncomplicated pregnancies, in which induction may be considered for other reasons. Nonetheless, a recently published retrospective cohort of 5090 women compared medically indicated with elective inductions, and rates of maternal and neonatal outcomes were found to be similar. 25 
Interpretation
The BS was initially developed for cervical assessment in parous women with uncomplicated pregnancies. 4 BS of 5 or lower was the predominant risk factor for CS in a prospective study of 1389 women who presented rates after IOL as high twice as that of women with spontaneous labour. 3 However, a systematic review of 40 studies showed that BS of 4, 5 or 6 was a poor predictor of the success of IOL and as such should not be used in the decision to induce or not. 5 Our results are in line with this assessment, as women randomised with BS in that range who were managed expectantly had CS rates similar to the women in the IOL group with comparable scores.
That notwithstanding, our results stand in clear contrast to several other studies that show higher risks of CS for nulliparas and multiparas after IOL. [6] [7] [8] [9] [10] [11] [12] These studies have been criticised for their use of spontaneous labour as the comparison group. 13 Comparing outcomes after spontaneous labour with those after IOL does not present a credible clinical scenario, as spontaneous labour is not a management choice of the obstetrician. The appropriate comparison group consists of women who were managed expectantly and later on went into labour spontaneously or in whom labour was induced when it was clearly medically indicated. This was found in a retrospective study of 19 377 women in which CS risk for nulliparas in the EM group was higher than in the IOL group at every term gestational age. 26 Furthermore, the largest randomised trial to date that compared IOL with EM showed lower CS rates after induction but only evaluated women with gestational ages of 41 weeks or more. 14 Another small trial studied pregnancies at and beyond 39 weeks and found similar rates of CS for both strategies; however, only women with a ripe cervix were included. 27 Finally, a recent systematic review of IOL versus EM concluded that CS risk was lower after IOL in women with intact membranes. 15 Our results correspond to these latter four studies, as we found comparable CS rates in women with an unripe cervix over a gestational age range of 36-41 weeks.
The other key finding of our analyses is that IOL does not lead to higher rates of adverse neonatal outcomes when compared with EM in women with an unripe cervix. Furthermore, we showed a significant benefit of IOL in women with an unripe cervix, as the difference in absolute rates of umbilical arterial pH <7.05 was estimated to be lowered by 3.2%. In a observational cohort of 51 519 term neonates, the relative risk of encephalopathy with seizures or death for those that presented umbilical arterial pH levels between 7.05 and 7.01 was 3.6. 28 This relative risk rose to 18.2 for pH levels ≤7.00. We showed that 32 women would need to be induced to avoid one case of umbilical arterial pH <7.05, and 39 women to avoid one case of pH <7.01. Studies of uncomplicated pregnancies presented longer times to delivery and higher costs associated with IOL. 6, 8, 13 In contrast, economic analyses of HYPITAT data found IOL to be less costly when antepartum resource use was taken into account and the same was found in DIGITAT data for gestational ages from 38 weeks on. 29, 30 Although IOL in our selected population may result in higher costs due to the longer time necessary to mature the cervix, we have shown that 75% of the women in the IOL group delivered within 2.5 days after randomisation and within 27 hours of induction start.
We favour a management strategy of IOL as opposed to elective CS for women with an unripe cervix and an indication for short-term delivery. The CS rate of 15.4% we observed justifies an attempt at vaginal delivery, as this will also result in less complicated future pregnancies. Naturally, the final management decision has to be made in close discussion with the woman herself.
In summary, we have shown that for women who present with an unripe cervix and had IOL for hypertensive disease or IUGR, the rates of CS and adverse neonatal outcomes are indistinguishable from those found in women who were managed expectantly. We have also presented evidence that BS between 3 and 6 are not associated with elevated rates of induction failure and CS.
Conclusion
We found no evidence that induction of labour increases the caesarean rate or compromises neonatal outcome as compared with expectant management in term or near term pregnancies complicated by IUGR, gestational hypertension or pre-eclampsia. Concerns over increased risk of failed induction in women with a Bishop score from 3 to 6 seem unwarranted.
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